Defining the therapeutic corridor of stability in enzyme replacement therapy for Pompe disease: a position statement
{{output}}
Background: Pompe disease, also known as glycogen storage disease type II, is a rare, progressive lysosomal storage disorder caused by pathogenic variants in the GAA gene. Enzyme replacement therapy has transformed the natural hi... ...
